• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
High-throughput quantitative microscopy-based half-life measurements of intravenously injected agents.基于高通量定量显微镜的静脉注射药物半衰期测量。
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3502-3508. doi: 10.1073/pnas.1915450117. Epub 2020 Feb 3.
2
Quantitative microscopy-based measurements of circulating nanoparticle concentration using microliter blood volumes.使用微升血液体积的基于定量显微镜的循环纳米颗粒浓度测量。
Nanomedicine. 2017 Aug;13(6):1863-1867. doi: 10.1016/j.nano.2017.04.003. Epub 2017 Apr 13.
3
The development and assessment of high-throughput mass spectrometry-based methods for the quantification of a nanoparticle drug delivery agent in cellular lysate.基于高通量质谱法的细胞裂解物中纳米颗粒药物递送剂定量方法的开发与评估。
J Mass Spectrom. 2014 Nov;49(11):1171-80. doi: 10.1002/jms.3444.
4
Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects.静脉注射用混悬剂:研发、临床前及临床方面的综述
Adv Drug Deliv Rev. 2008 May 22;60(8):939-54. doi: 10.1016/j.addr.2007.11.008. Epub 2008 Feb 7.
5
Addressing the challenges of low clearance in drug research.应对药物研究中低清除率的挑战。
AAPS J. 2015 Mar;17(2):352-7. doi: 10.1208/s12248-014-9691-7. Epub 2015 Jan 8.
6
Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay.通过灵敏且精确的高效液相色谱法测定小鼠生物样品中阿霉素的生物利用度。
Pharm Biol. 2016;54(1):55-61. doi: 10.3109/13880209.2015.1014918. Epub 2015 Apr 16.
7
Half-life of murine IgE antibodies in the mouse.小鼠体内鼠源IgE抗体的半衰期。
Int Arch Allergy Appl Immunol. 1983;71(2):182-4. doi: 10.1159/000233385.
8
Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.聚(L-丙交酯)-聚(乙二醇)纳米粒在大鼠和荷瘤鼠体内的药物传递特性的综合研究。
J Control Release. 2017 Sep 10;261:31-42. doi: 10.1016/j.jconrel.2017.06.006. Epub 2017 Jun 10.
9
High-throughput in vitro drug release and pharmacokinetic simulation as a tool for drug delivery system development: application to intravitreal ocular administration.高通量体外药物释放和药代动力学模拟作为药物递送系统开发的工具:在玻璃体内眼内给药中的应用。
Int J Pharm. 2014 Dec 30;477(1-2):469-75. doi: 10.1016/j.ijpharm.2014.10.062. Epub 2014 Oct 31.
10
High-Throughput, Algorithmic Determination of Nanoparticle Structure from Electron Microscopy Images.高通量,基于算法的电子显微镜图像纳米颗粒结构测定。
ACS Nano. 2015 Dec 22;9(12):12488-95. doi: 10.1021/acsnano.5b05968. Epub 2015 Nov 20.

引用本文的文献

1
Cellular determinants influence the red blood cell adsorption efficiency of poly(amine--ester) nanoparticles.细胞决定因素影响聚(胺 - 酯)纳米颗粒对红细胞的吸附效率。
Sci Adv. 2025 May 2;11(18):eadt8637. doi: 10.1126/sciadv.adt8637.
2
The Incorporation of CBD into Biodegradable DL-Lactide/Glycolide Copolymers Creates a Persistent Antibacterial Environment: An In Vitro Study on and .将大麻二酚掺入可生物降解的丙交酯/乙交酯共聚物中可营造持久抗菌环境:关于……的体外研究
Pharmaceutics. 2025 Apr 2;17(4):463. doi: 10.3390/pharmaceutics17040463.
3
Investigation of the protein corona and biodistribution profile of polymeric nanoparticles for intra-amniotic delivery.用于羊膜腔内给药的聚合物纳米颗粒的蛋白质冠层和生物分布概况研究。
Biomaterials. 2025 Sep;320:123238. doi: 10.1016/j.biomaterials.2025.123238. Epub 2025 Mar 6.
4
Enhancing in vivo cell and tissue targeting by modulation of polymer nanoparticles and macrophage decoys.通过调节聚合物纳米颗粒和巨噬细胞诱饵来增强体内细胞和组织的靶向性。
Nat Commun. 2024 May 18;15(1):4247. doi: 10.1038/s41467-024-48442-7.
5
Modifying the Backbone Chemistry of PEG-Based Bottlebrush Block Copolymers for the Formation of Long-Circulating Nanoparticles.修饰基于 PEG 的瓶刷嵌段共聚物的骨架化学,以形成长循环纳米粒子。
Adv Healthc Mater. 2024 Sep;13(22):e2304040. doi: 10.1002/adhm.202304040. Epub 2024 May 22.
6
Nanoscale Surface Topography of Polyethylene Glycol-Coated Nanoparticles Composed of Bottlebrush Block Copolymers Prolongs Systemic Circulation and Enhances Tumor Uptake.由刷型嵌段共聚物组成的聚乙二醇包覆纳米粒子的纳米级表面形貌延长了系统循环时间并增强了肿瘤摄取。
ACS Nano. 2024 Jan 30;18(4):2815-2827. doi: 10.1021/acsnano.3c05921. Epub 2024 Jan 16.
7
Rational nanoparticle design: Optimization using insights from experiments and mathematical models.理性纳米粒子设计:从实验和数学模型中获得的见解进行优化。
J Control Release. 2023 Aug;360:772-783. doi: 10.1016/j.jconrel.2023.07.018. Epub 2023 Jul 22.
8
In vivo correction of cystic fibrosis mediated by PNA nanoparticles.肽核酸纳米颗粒介导的囊性纤维化体内校正。
Sci Adv. 2022 Oct 7;8(40):eabo0522. doi: 10.1126/sciadv.abo0522. Epub 2022 Oct 5.
9
PEGylation of poly(amine-co-ester) polyplexes for tunable gene delivery.聚(胺-酯)共聚物的聚乙二醇化用于基因传递的可调控制。
Biomaterials. 2021 May;272:120780. doi: 10.1016/j.biomaterials.2021.120780. Epub 2021 Mar 24.
10
Polymeric vehicles for nucleic acid delivery.核酸递送用聚合物载体。
Adv Drug Deliv Rev. 2020;156:119-132. doi: 10.1016/j.addr.2020.06.014. Epub 2020 Jun 23.

本文引用的文献

1
Preferential Tumor Accumulation of Polyglycerol Functionalized Nanodiamond Conjugated with Cyanine Dye Leading to Near-Infrared Fluorescence In Vivo Tumor Imaging.聚甘油功能化纳米金刚石与菁染料偶联物的肿瘤优先积累导致近红外荧光体内肿瘤成像。
Small. 2019 Nov;15(48):e1901930. doi: 10.1002/smll.201901930. Epub 2019 Jul 1.
2
Layer-by-layer nanoparticles for novel delivery of cisplatin and PARP inhibitors for platinum-based drug resistance therapy in ovarian cancer.用于顺铂和PARP抑制剂新型递送的层层组装纳米颗粒,用于卵巢癌铂类耐药治疗
Bioeng Transl Med. 2019 Jun 14;4(2):e10131. doi: 10.1002/btm2.10131. eCollection 2019 May.
3
Surface protein engineering increases the circulation time of a cell membrane-based nanotherapeutic.表面蛋白工程增加了基于细胞膜的纳米治疗剂的循环时间。
Nanomedicine. 2019 Jun;18:169-178. doi: 10.1016/j.nano.2019.02.024. Epub 2019 Mar 8.
4
Priming the body to receive the therapeutic agent to redefine treatment benefit/risk profile.使机体对治疗药物产生反应,重新定义治疗获益/风险状况。
Sci Rep. 2018 Mar 19;8(1):4797. doi: 10.1038/s41598-018-23140-9.
5
Quantitative microscopy-based measurements of circulating nanoparticle concentration using microliter blood volumes.使用微升血液体积的基于定量显微镜的循环纳米颗粒浓度测量。
Nanomedicine. 2017 Aug;13(6):1863-1867. doi: 10.1016/j.nano.2017.04.003. Epub 2017 Apr 13.
6
Strategies and challenges for the next generation of antibody-drug conjugates.下一代抗体药物偶联物的策略与挑战。
Nat Rev Drug Discov. 2017 May;16(5):315-337. doi: 10.1038/nrd.2016.268. Epub 2017 Mar 17.
7
Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics.用于体内高通量发现靶向治疗药物的条形码纳米颗粒。
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):2060-2065. doi: 10.1073/pnas.1620874114. Epub 2017 Feb 6.
8
The state-of-play and future of antibody therapeutics.抗体治疗药物的现状与未来。
Adv Drug Deliv Rev. 2017 Dec 1;122:2-19. doi: 10.1016/j.addr.2016.11.004. Epub 2016 Dec 2.
9
Coming-of-Age of Antibodies in Cancer Therapeutics.抗体在癌症治疗中的成熟之路。
Trends Pharmacol Sci. 2016 Dec;37(12):1009-1028. doi: 10.1016/j.tips.2016.09.005. Epub 2016 Oct 10.
10
The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction.纳米颗粒大小对体内药代动力学和细胞相互作用的影响。
Nanomedicine (Lond). 2016 Mar;11(6):673-92. doi: 10.2217/nnm.16.5. Epub 2016 Mar 22.

基于高通量定量显微镜的静脉注射药物半衰期测量。

High-throughput quantitative microscopy-based half-life measurements of intravenously injected agents.

机构信息

Department of Biomedical Engineering, Yale University, New Haven, CT 06511.

Department of Surgery, Yale School of Medicine, New Haven, CT 06511.

出版信息

Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3502-3508. doi: 10.1073/pnas.1915450117. Epub 2020 Feb 3.

DOI:10.1073/pnas.1915450117
PMID:32015123
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7035491/
Abstract

Accurate analysis of blood concentration and circulation half-life is an important consideration for any intravenously administered agent in preclinical development or for therapeutic application. However, the currently available tools to measure these parameters are laborious, expensive, and inefficient for handling multiple samples from complex multivariable experiments. Here we describe a robust high-throughput quantitative microscopy-based method to measure the blood concentration and circulation half-life of any fluorescently labeled agent using only a small (2 µL) amount of blood volume, enabling additional end-point measurements to be assessed in the same subject. To validate this method, we demonstrate its use to measure the circulation half-life in mice of two types of fluorescently labeled polymeric nanoparticles of different sizes and surface chemistries and of a much smaller fluorescently labeled monoclonal antibody. Furthermore, we demonstrate the improved accuracy of this method compared to previously described methods.

摘要

准确分析血药浓度和循环半衰期是临床前开发或治疗应用中任何静脉内给予药物的重要考虑因素。然而,目前可用的测量这些参数的工具繁琐、昂贵且效率低下,无法处理来自复杂多变量实验的多个样本。在这里,我们描述了一种强大的高通量定量显微镜方法,仅使用少量(2 µL)血量即可测量任何荧光标记试剂的血药浓度和循环半衰期,从而能够在同一对象中评估其他终点测量。为了验证这种方法,我们证明了它在测量两种不同大小和表面化学性质的荧光标记聚合物纳米粒子以及一种更小的荧光标记单克隆抗体在小鼠体内的循环半衰期中的用途。此外,我们证明了与以前描述的方法相比,该方法具有更高的准确性。